Europe Home Healthcare Market Analysis and Forecast by Size, Share, Growth, Trends 2031

Europe Home Healthcare Market Size and Forecast (2021–2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Services (Skilled Nursing Care, Physical Therapy, Rehabilitation Therapy, Speech Therapy, and Others), Type (Therapeutic, Diagnostic, and Mobility Assist), and Indication (Cancer, Respiratory Diseases, Mobility Disorders, Cardiovascular Disorders, Wound Care, Diabetes, and Other)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Status : Published
  • Report Code : TIPRE00023453
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
Buy Now  
Europe Home Healthcare Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: Mar 2026   |   Report Code: TIPRE00023453
Buy Now

The Europe home healthcare market size is expected to reach US$ 1,68,108.00 million by 2031 from US$ 95,565.78 million in 2024. The market is estimated to record a CAGR of 8.4% from 2024 to 2031.

Executive Summary and Europe Home Healthcare Market Analysis:

Europe has the second-largest share in the global home medical devices market. This is due to several key factors in countries like France, Germany, the UK, Italy, and Spain. One major factor is the rising demand for home health and personal care aides. More patients, especially the elderly who need ongoing monitoring and assistance, prefer to receive care at home. The region's strong emphasis on research and development in medical technology significantly boosts the availability of innovative home medical devices. Additionally, Europe’s aging population is growing quickly, which increases the need for accessible and effective healthcare solutions that allow for independent living. Home healthcare is seen as a cost-effective alternative to hospital care, and this is driving market demand. Moreover, rising investments and funding in medical device innovation, along with the use of advanced technologies like artificial intelligence and medical robotics, are expected to create strong growth opportunities. These advancements will improve the effectiveness and convenience of home healthcare services in the region.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Europe Home Healthcare Market: Strategic Insights

Europe Home Healthcare Market
  • Market Size 2024
    US$ 95,565.78 Million
  • Market Size 2025-2031
    US$ 1,68,108.00 Million

Market Dynamics

GROWTH DRIVERS
  • Increasing Prevalence of Chronic Diseases Among the Aging Population
  • Cost-effectiveness of Home Healthcare
FUTURE TRENDS
  • Adoption of Advanced Technologies in Homecare Settings
OPPORTUNITIES
  • Growing Government Support for Home Healthcare

Regional Overview

Regional Overview
  • Europe

Market Segmentation

cust_bullet_danger Services
  • Skilled Nursing Care
  • Physical Therapy
  • Rehabilitation Therapy
  • Speech Therapy
  • Others
cust_bullet_warning Type
  • Therapeutic
  • Diagnostic
  • Mobility Assist
cust_bullet_primary Indication
  • Cancer
  • Respiratory Diseases
  • Mobility Disorders
  • Cardiovascular Disorders
  • Wound Care
  • Diabetes
  • Other
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Home Healthcare Market Segmentation Analysis:

Key segments that contributed to the derivation of the Europe home healthcare market analysis are services, type, and indication.

  • By services, the Europe home healthcare market is segmented into skilled nursing care, physical therapy, rehabilitation therapy, speech therapy, and others. The skilled nursing care segment held the largest share of the market in 2024.
  • By type, the Europe home healthcare market is segmented into therapeutic, diagnostic, and mobility assist. The therapeutic segment held the largest share of the market in 2024.
  • By indication, the Europe home healthcare market is segmented into cancer, respiratory diseases, mobility disorders, cardiovascular disorders, wound care, diabetes, and other. The respiratory diseases segment held the largest share of the market in 2024.

Europe Home Healthcare Market Report Scope

Report Attribute Details
Market size in 2024 US$ 95,565.78 Million
Market Size by 2031 US$ 1,68,108.00 Million
CAGR (2024 - 2031) 8.4%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Services
  • Skilled Nursing Care
  • Physical Therapy
  • Rehabilitation Therapy
  • Speech Therapy
  • Others
By Type
  • Therapeutic
  • Diagnostic
  • Mobility Assist
By Indication
  • Cancer
  • Respiratory Diseases
  • Mobility Disorders
  • Cardiovascular Disorders
  • Wound Care
  • Diabetes
  • Other
Regions and Countries Covered Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Enhabit Home Health & Hospice
  • Apollo HomeCare
  • Cura Mexico
  • Koninklijke Philips NV
  • LHC Group Inc
  • BAYADA Home Health Care
  • Mears Group Plc
  • Abbott Care
  • Amedisys Inc
  • Kindred Healthcare, LLC
  • CenterWell Home Health

Europe Home Healthcare Market Outlook

Cost-effectiveness has emerged as a prominent factor in healthcare delivery models globally, prompting a growing interest in home healthcare options. Medical care in homes enables less reliance on hospital setups, which tend to be more expensive. This also enhances the comfort of the patients while aiding healthcare systems in controlling costs better in different parts of the world. For example, the European Observatory on Health Systems and Policies in December 2022 discovered that home healthcare programs accounted for a 22% decrease in institutional care expenses, especially in France and Germany. The savings were made possible through reduced hospital stays and improved control of long-term conditions at home. This shows how the cost-saving benefits of home healthcare are fueling its increased uptake around the world. As health systems seek to maximize resources and ensure the quality of care, home-based services remain a key factor in helping them do so.

Europe Home Healthcare Market Country Insights

Based on country, the Europe home healthcare market comprises the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2024.

The growth of the home healthcare market in Germany is driven by the growing prevalence of target diseases, especially Alzheimer’s and other dementias, and the rising aging population. More than 24 million of the population are of the age group of 60 years, and about 900,000 people dwell in home healthcare as the geriatric population is at higher risk for chronic diseases. Various factors assist Germany in holding the top position in the medical device industry. As per the International Trade Administration, Germany claims the third-largest medical technology market in the world after the United States and Japan and is by far the largest European market, twice the size of the French market and three times as large as those of Italy, the United Kingdom, and Spain. The majority of the medical technology and device companies are based in Germany, whereas small and medium companies account for nearly 95% of the total medical device industry.

Europe Home Healthcare Market Company Profiles

Some of the key players operating in the market include Enhabit Home Health & Hospice, Apollo HomeCare, Cura Mexico, Koninklijke Philips NV, LHC Group Inc, BAYADA Home Health Care, Mears Group Plc, Abbott Care, Amedisys Inc, Kindred Healthcare, LLC; and CenterWell Home Healths, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Home Healthcare Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

  • Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations.
  • Industry trade journals and other relevant publications.
  • Government documents, statistical databases, and market reports.
  • News articles, press releases, and webcasts specific to companies operating in the market.

Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

  • Primary Research

The Insight Partners’ conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research.
  • Enhance the expertise and market understanding of the analysis team.
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Frequently Asked Questions

Home healthcare includes a wide range of healthcare services for illness in homecare settings. The goal of home healthcare is to treat injury and improve health outcomes for the patient. These services are more convenient and less expensive and are efficient for chronic diseases, elderly population, nutrition therapy and serious illness of the patient.

The growth of the market is estimated to grow owing to key driving factors such as, increasing demand for home healthcare due to aging population and increasing prevalence of chronic diseases along with increasing homecare settings across the region.

The dearth of skilled homecare workers and professionals is likely to have a negative impact on the growth of the Europe home healthcare market in the coming years.

The key players in the Europe Home Healthcare market are Fresenius Medical Care AG & Co KGaA, Koninklijke Philips N.V., Sciensus, LINDE, OMRON Corporation, BAYADA Home Health Care, Invacare Corporation, B. Braun Melsungen AG, Mears Group PLC, AIR LIQUIDE SA among others.

The market players in the regional market in constantly involved in product development and innovations as part of their business strategies such as product launch, mergers and acquisitions, partnership, collaboration and others. For instance, in April 2020, Fresenius Medical Care announced that it enhances its home dialysis offering in the company’s Europe, Middle East and Africa (EMEA) region.

Germany held the largest share in the Europe home healthcare market. The growth of the market in this region is primarily due to the rising demand for home healthcare across the country along with a surge in the prevalence of chronic disorders and mobility disorders.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA
Page Updated: Mar 2026